Updates

• Security Code: 533259
• Company: SASTASUNDR

Update to disclosure on September 28, 2015 by Sastasundar Ventures Limited (the 'Company') & Notice pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 We, Sastasundar Ventures Limited (then known as Microsec Financial Services Limited) had made a disclosure on September 28, 2015 (enclosed herewith) of the outcome of our annual general meeting held on September 28, 2015 where the members of the Company were informed of potential investments in our subsidiary, Sastasundar Healthbuddy Limited (then known as Microsec Health Buddy Limited), ('SHBL'). In continuation of the above disclosure, we wish to inform you that SHBL and the Company have executed a share subscription agreement today with Rohto Pharmaceutical Co., Ltd., a company incorporated and listed in Japan ('Rohto') and engaged in manufacturing and marketing of pharmaceutical products, cosmetics and functional foods, in relation to a proposed investment in SHBL by Rohto. Rohto has agreed to subscribe to an aggregate of 24,35,583 (Twenty Four Lakhs Thirty Five Thousand Five Hundred and Eighty Three) equity shares of face value of INR 10 (Rupees Ten only) each, constituting 13% (thirteen percent) of the share capital of SHBL on a fully diluted basis for an aggregate investment amount of Rupees equivalent of US$ 5,000,000 (United States Dollar Five Million). The issue of equity shares as aforesaid and execution of a shareholders agreement with Rohto in relation to management and governance of SHBL will be completed within 45 days from the date of execution. Rohto is not related to the promoter/promoter group/group companies of the Company in any manner, nor is it a related party to the Company. This intimation is issued to you pursuant to Regulation 30 of the provisions of the Listing Regulation.